These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 239183)

  • 1. Effects of a dopamine beta-hydroxylase inhibitor on amphetamine-induced hyperactivity in rats.
    Khalsa JH; Davis WM
    J Pharm Pharmacol; 1975 Aug; 27(8):620-2. PubMed ID: 239183
    [No Abstract]   [Full Text] [Related]  

  • 2. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell nuclear accumulation of estrogen receptors in rat brain and pituitary gland after treatment with a dopamine-beta-hydroxylase inhibitor.
    Blaustein JD
    Neuroendocrinology; 1986; 42(1):44-50. PubMed ID: 3941758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two inhibitors of dopamine beta-hydroxylase on maturation of memory in mice.
    Flexner JB; Flexner LB
    Pharmacol Biochem Behav; 1976 Aug; 5(2):117-21. PubMed ID: 996046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic role in the self-administration of morphine or amphetamine.
    Davis WM; Smith SG; Khalsa JH
    Pharmacol Biochem Behav; 1975; 3(3):477-84. PubMed ID: 168592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
    [No Abstract]   [Full Text] [Related]  

  • 9. The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs.
    Thornburg JE; Moore KE
    Neuropharmacology; 1973 Sep; 12(9):853-66. PubMed ID: 4147726
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect with time of a norepinephrine synthesis inhibitor (U-14,624) on hypothalamic catecholamine and plasma gonadotrophin concentrations in the ovariectomized rat.
    Kohn SR; Morgan WW; Carrillo AJ
    J Reprod Fertil; 1982 Sep; 66(1):185-8. PubMed ID: 6811733
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of unithiol (2-mercapto-propane-sulfonate sodium) on amphetamine stimulated motor activity, evipan anesthesia and dopamine beta hydroxylase activity].
    Stoĭchev T; Koleva M; Kirova A
    Eksp Med Morfol; 1974; 13(2):118-23. PubMed ID: 4465084
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the catecholamine-depleting agent 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624) on drug metabolism in the rat.
    Smith JR; Waters IW; Masten LW
    Biochem Pharmacol; 1980 Sep; 29(18):2425-30. PubMed ID: 7426048
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of unithiol (2-mercapto-propane sulfonate sodium) on the motor activity stimulated by amphetamine, on evipan anesthesia and on the activity of dopamine-beta-hydroxylase].
    Stoichev Ts; Koleva M; Kirova A
    Eksp Med Morfol; 1974; 13(2):118-23. PubMed ID: 4374349
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation and blockade of the central action of amphetamine by chlorpromazine.
    Sulser F; Dingell JV
    Biochem Pharmacol; 1968 Apr; 17(4):634-6. PubMed ID: 5649556
    [No Abstract]   [Full Text] [Related]  

  • 16. Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis.
    Colussi-Mas J; Panayi F; Scarna H; Renaud B; Bérod A; Lambás-Señas L
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):569-81. PubMed ID: 15836801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for reversible inhibition of brain dopamine-beta-hydroxylase activity in vivo by amphetamine analogues.
    Stolk JM
    J Neurochem; 1975 Jan; 24(1):135-42. PubMed ID: 1110356
    [No Abstract]   [Full Text] [Related]  

  • 18. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
    Sershen H; Harsing LG; Hashim A; Lajtha A
    Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lithium and other drugs on the amphetamine chlordiazeposice hyperactivity in mice.
    Poitou P; Boulu R; Bohuon C
    Experientia; 1975 Jan; 31(1):99-101. PubMed ID: 122937
    [No Abstract]   [Full Text] [Related]  

  • 20. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.